吲哚布芬对NA预收缩的大鼠离体胸主动脉环张力的影响(3)
第1页 |
参见附件(1993KB,3页)。
[5] Cataldo G,Heiman F,Lavezzari M,et al.Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery:Results of a combined analysis[J].Coron Artery Dis,1998,9(4):217-222.
[6] Moncada S,Palmer RM,Higgs EA.Nitric oxide:Physiology,pathophysiology,and pharmacology[J].Pharmacol Rev,1991,43(2):109-142.
[7] Palmer RM,Ferrige AG,Moncada S.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J].Nature,1987,327(6122):524-526.
[8] Palmer RM,Rees DD,Ashton DS,et al.L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation[J].Biochem Biophys Res Commun,1988,153(3):1251-1256.
[9] Vaandrager AB,de Jonge HR.Signalling by cGMP-dependent protein kinases [J].Mol Cell Biochem,1996,157(1-2):23-30.
[10] Vanhoutte PM.内皮源性超极化因子[M].修瑞娟,译.北京:世界图书出版公司,1999:41-51.
[11] Nelson MT,Quayle JM.Physiological roles and properties of potassium channels in arterial smooth muscle [J].Am J Physiol,1995,268(4 Pt 1):C799-822.
[12] Jackson WF.Ion channels and vascular tone[J].Hypertension,2000,35(1 Pt 2):173-178.
作者简介:李昱(1981—),男,现为山西医科大学药理学在读硕士研究生(邮编:030001);张明升(通讯作者)、武冬梅、任俊杰、张轩萍、梁月琴,工作于山西医科大学(邮编:030001)。
(收稿日期:2011-02-26)
(本文编辑 郭怀印)
您现在查看是摘要介绍页,详见PDF附件(1993KB,3页)。